UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number 001-42548
| (Check One) |
☒ |
Form 10-K |
☐ |
Form 20-F |
☐ |
Form 11-K |
☐ |
Form 10-Q |
☐ |
Form 10-D |
☐ |
Form N-CEN |
☐ |
Form N-CSR |
For Period Ended: June 30, 2026
☐
Transition Report on Form 10-K
☐
Transition Report on Form 20-F
☐
Transition Report on Form 11-K
☐
Transition Report on Form 10-Q
For the Transition Period Ended: ________________________
| |
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
If the notification relates to a portion of the filing
checked above, identify the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Advanced Biomed Inc.
Full Name of Registrant
N/A
Former Name if Applicable
No. 689-85 Xiaodong Road, Yongkang District
Address of Principal Executive Office (Street and Number)
Tainan City, Taiwan 71052
City, State, Zip Code
PART II - RULES 12b-25(b) AND (c)
| |
(a) |
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| |
|
|
| ☒ |
(b) |
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| |
|
|
| |
(c) |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III - NARRATIVE
State below in reasonable detail why the Form 10-K,
20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach
extra sheets if needed.)
The Registrant is unable to file its Form 10-K Annual
Report for the period ended June 30, 2026, within the prescribed time period without unreasonable effort or expense, as the audit of its
financial statements has not yet been completed. The Registrant anticipates that the Form 10-K Annual Report, together with the financial
statements, will be filed within the prescribed extension period.
PART IV - OTHER INFORMATION
| (1) |
Name and telephone number of person to contact in regard to this notification: |
| Xiaomin Chen |
|
(886) |
|
6-3121716 |
| Name |
|
Area Code |
|
Telephone |
| (2) |
Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No |
| (3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No |
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Advanced Biomed Inc.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf
by the undersigned, thereunto duly authorized.
| Date: September 28, 2026 |
|
| |
|
| By: |
/s/ Xiaomin Chen |
|
| Name: |
Xiaomin Chen |
|
| Title: |
Chief Executive Officer |
|
